Literature DB >> 25367126

T cell mediated autoimmune glomerular disease in mice.

Joshua D Ooi1, Poh-Yi Gan1, Dragana Odobasic1, Stephen R Holdsworth1,2, A Richard Kitching1,2,3.   

Abstract

Many forms of glomerulonephritis are mediated by autoimmunity. While autoantibodies are often pathogenic, cell-mediated immunity plays an important role in a number of forms of rapidly progressive glomerulonephritis. This unit describes the induction of cell-mediated autoimmune glomerular disease in mice. One disease model, experimental anti-glomerular basement membrane (GBM) disease, features autoreactivity to a well-defined component of type IV collagen found in the GBM, α3(IV)NC1. The other models the cell-mediated effector response in forms of renal vasculitis, where autoantibodies to myeloperoxidase result in systemic neutrophil activation, resulting in their localization to the glomerulus and the subsequent deposition of myeloperoxidase within glomerular capillaries. There, myeloperoxidase acts as a "planted" autoantigen and is recognized by effector autoreactive myeloperoxidase-specific T cells. These models are useful both in defining mechanisms germane to the development of autoimmunity to α3(IV)NC1 and myeloperoxidase, and in dissecting the role of cell-mediated responses in effecting glomerular injury.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  T lymphocytes; autoimmunity; cell-mediated immunity; glomerulonephritis

Mesh:

Substances:

Year:  2014        PMID: 25367126     DOI: 10.1002/0471142735.im1527s107

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  5 in total

Review 1.  Galectin-3 in autoimmunity and autoimmune diseases.

Authors:  Felipe L de Oliveira; Mariele Gatto; Nicola Bassi; Roberto Luisetto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-03

2.  What is myeloperoxidase doing in ANCA-associated glomerulonephritis?

Authors:  William G Couser; Richard J Johnson
Journal:  Kidney Int       Date:  2015-11       Impact factor: 10.612

Review 3.  Biologics for the treatment of autoimmune renal diseases.

Authors:  Stephen R Holdsworth; Poh-Yi Gan; A Richard Kitching
Journal:  Nat Rev Nephrol       Date:  2016-03-07       Impact factor: 28.314

Review 4.  Emerging immunotherapies for autoimmune kidney disease.

Authors:  Mary Helen Foster; Jeffrey Robinson Ord
Journal:  Hum Vaccin Immunother       Date:  2019-01-16       Impact factor: 4.526

5.  A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity.

Authors:  Joshua D Ooi; Jhih-Hang Jiang; Peter J Eggenhuizen; Ling L Chua; Mirjan van Timmeren; Khai L Loh; Kim M O'Sullivan; Poh Y Gan; Yong Zhong; Kirill Tsyganov; Lani R Shochet; Jessica Ryan; Coen A Stegeman; Lars Fugger; Hugh H Reid; Jamie Rossjohn; Peter Heeringa; Stephen R Holdsworth; Anton Y Peleg; A Richard Kitching
Journal:  Nat Commun       Date:  2019-07-29       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.